Cboe US - Nasdaq Real Time Price USD

ARK Genomic Revolution ETF (ARKG)

26.60 +0.07 (+0.28%)
As of 1:33 PM EDT. Market Open.
Loading Chart for ARKG
DELL
  • Previous Close 26.53
  • Open 26.56
  • Bid 26.65 x 1000
  • Ask 26.66 x 800
  • Day's Range 26.18 - 26.73
  • 52 Week Range 21.97 - 38.97
  • Volume 1,300,988
  • Avg. Volume 2,462,520
  • Net Assets 1.31B
  • NAV 26.51
  • PE Ratio (TTM) --
  • Yield 0.00%
  • YTD Daily Total Return -19.14%
  • Beta (5Y Monthly) 1.77
  • Expense Ratio (net) 0.75%

The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified.

ARK ETF Trust

Fund Family

Health

Fund Category

1.31B

Net Assets

2014-10-31

Inception Date

Performance Overview: ARKG

Trailing returns as of 5/17/2024. Category is Health.

YTD Return

ARKG
19.14%
Category
0.45%
 

1-Year Return

ARKG
12.38%
Category
1.63%
 

3-Year Return

ARKG
29.56%
Category
3.64%
 

People Also Watch

Holdings: ARKG

Top 10 Holdings (48.50% of Total Assets)

SymbolCompany% Assets
CRSP
CRISPR Therapeutics AG 7.04%
TWST
Twist Bioscience Corporation 6.78%
RXRX
Recursion Pharmaceuticals, Inc. 5.49%
EXAS
Exact Sciences Corporation 5.27%
SDGR
Schrödinger, Inc. 4.69%
IONS
Ionis Pharmaceuticals, Inc. 4.41%
NTLA
Intellia Therapeutics, Inc. 3.93%
TXG
10x Genomics, Inc. 3.81%
DNA
Ginkgo Bioworks Holdings, Inc. 3.60%
BEAM
Beam Therapeutics Inc. 3.48%

Sector Weightings

SectorARKG
Healthcare   98.88%
Technology   1.12%
Real Estate   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Recent News: ARKG

Research Reports: ARKG

Related Tickers